DIGBF yields 4.76% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, DIGBF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DIGBF + JNJ for your $10,000?
Celcomdigi Berhad, an investment holding company, provides mobile communication services and related products in Malaysia. It engages in the establishment, maintenance, and provision of telecommunication and related services; trading and distribution of communication devices and related products; managing retail stores; and fibre optic transmission network and property investment activities. The company also offers e-commerce, and digital services and solutions; telecommunication infrastructure services; cybersecurity, networking, information, and communication solutions; business management and integration systems; and strategic and business development, management, and administrative support services. In addition, it provides network communications, capacity, and services; mobile communications and network transmission related services; network and application services; and content solutions. The company was formerly known as Digi.Com Berhad and changed its name to Celcomdigi Berhad in February 2023. Celcomdigi Berhad was founded in 1995 and is headquartered in Petaling Jaya, Malaysia.
Full DIGBF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.